Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia.

Aoyama N, Théberge J, Drost DJ, Manchanda R, Northcott S, Neufeld RW, Menon RS, Rajakumar N, Pavlosky WF, Densmore M, Schaefer B, Williamson PC.

Br J Psychiatry. 2011 Jun;198(6):448-56. doi: 10.1192/bjp.bp.110.079608.

2.

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia.

Théberge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK, Northcott S, Menon RS, Neufeld RW, Rajakumar N, Pavlosky W, Densmore M, Schaefer B, Williamson PC.

Br J Psychiatry. 2007 Oct;191:325-34.

3.

An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients.

Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, Thompson RT.

Schizophr Bull. 1996;22(4):597-609.

PMID:
8938914
4.

Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.

Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.

Pharmacopsychiatry. 2011 Jun;44(4):148-57. doi: 10.1055/s-0031-1279739. Epub 2011 Jun 27.

PMID:
21710405
5.

Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.

J Psychiatr Res. 2007 Oct;41(8):625-34. Epub 2006 Sep 1.

PMID:
16949099
6.

Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.

Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ.

Am J Psychiatry. 2003 Dec;160(12):2231-3.

PMID:
14638596
7.

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers.

Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al-Semaan Y, Williamson PC.

Am J Psychiatry. 2002 Nov;159(11):1944-6.

PMID:
12411236
8.

1H-MRS at 4 tesla in minimally treated early schizophrenia.

Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, Hammond R, Brooks WM, Lauriello J.

Mol Psychiatry. 2010 Jun;15(6):629-36. doi: 10.1038/mp.2009.121. Epub 2009 Nov 17.

9.

A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.

Reid MA, White DM, Kraguljac NV, Lahti AC.

Schizophr Res. 2016 Feb;170(2-3):341-50. doi: 10.1016/j.schres.2015.12.003. Epub 2015 Dec 21.

PMID:
26718333
10.

1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia.

Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N, Abe O, Kasai K, Tsujii K, Iwanami A, Aoki S, Ohtomo K, Kato N, Kato T.

Neuroreport. 2002 Nov 15;13(16):2133-7.

PMID:
12438941
11.

Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study.

van Elst LT, Valerius G, Büchert M, Thiel T, Rüsch N, Bubl E, Hennig J, Ebert D, Olbrich HM.

Biol Psychiatry. 2005 Nov 1;58(9):724-30. Epub 2005 Jul 14.

PMID:
16018980
12.

Glutamatergic metabolite correlations with neuropsychological tests in first episode schizophrenia.

Dempster K, Norman R, Théberge J, Densmore M, Schaefer B, Williamson P.

Psychiatry Res. 2015 Aug 30;233(2):180-5. doi: 10.1016/j.pscychresns.2015.06.003. Epub 2015 Jun 19.

PMID:
26163385
13.

Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.

Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC.

Psychiatry Res. 2004 Jul 30;131(2):107-14.

PMID:
15313517
14.

Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment.

Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, Wong JC, Lienenkaëmper N, Cheung V, Suckling J, McAlonan GM.

Psychol Med. 2009 May;39(5):793-800. doi: 10.1017/S0033291708004212. Epub 2008 Aug 20.

PMID:
18713487
15.

Evidence for glutamatergic neuronal dysfunction in the prefrontal cortex in chronic but not in first-episode patients with schizophrenia: a proton magnetic resonance spectroscopy study.

Ohrmann P, Siegmund A, Suslow T, Spitzberg K, Kersting A, Arolt V, Heindel W, Pfleiderer B.

Schizophr Res. 2005 Mar 1;73(2-3):153-7.

PMID:
15653258
16.

Interindividual, repositioning, and time-of-day effects on single voxel proton MR spectroscopy of the anterior cingulate cortex.

Soreni N, Noseworthy MD, Konyer NB, Pullenayegum E, Schachar R.

J Magn Reson Imaging. 2010 Aug;32(2):276-82. doi: 10.1002/jmri.22264.

PMID:
20677251
17.

Longitudinal 4.0 Tesla (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia.

Miller J, Williamson P, Jensen JE, Manchanda R, Menon R, Neufeld R, Rajakumar N, Pavlosky W, Densmore M, Schaefer B, Drost DJ.

Psychiatry Res. 2009 Aug 30;173(2):155-7. doi: 10.1016/j.pscychresns.2008.10.001. Epub 2009 Jun 11.

PMID:
19520552
18.

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

Abbott C, Bustillo J.

Curr Opin Psychiatry. 2006 Mar;19(2):135-9. Review.

PMID:
16612192
19.

Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.

Jensen JE, Miller J, Williamson PC, Neufeld RW, Menon RS, Malla A, Manchanda R, Schaefer B, Densmore M, Drost DJ.

Psychiatry Res. 2006 Mar 31;146(2):127-35. Epub 2006 Feb 23.

PMID:
16497488
20.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Biol Psychiatry. 2000 Feb 15;47(4):305-13.

PMID:
10686265

Supplemental Content

Support Center